MENU
+Compare
SCNX
Stock ticker: NASDAQ
AS OF
Jul 16, 02:09 PM (EDT)
Price
$1.93
Change
+$0.21 (+12.28%)
Capitalization
12.34M

SCNX stock forecast, quote, news & analysis

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company... Show more

SCNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SCNX with price predictions
Jul 15, 2025

SCNX in upward trend: 10-day moving average broke above 50-day moving average on June 10, 2025

The 10-day moving average for SCNX crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 01, 2025. You may want to consider a long position or call options on SCNX as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCNX just turned positive on July 01, 2025. Looking at past instances where SCNX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

SCNX moved above its 50-day moving average on June 30, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 90 cases where SCNX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SCNX broke above its upper Bollinger Band on July 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SCNX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.028) is normal, around the industry mean (3.463). P/E Ratio (0.000) is within average values for comparable stocks, (181.246). SCNX's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.915). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. SCNX's P/S Ratio (1.977) is slightly higher than the industry average of (0.903).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Dividends

SCNX paid dividends on July 24, 2024

Scienture Holdings Inc SCNX Stock Dividends
А quarterly dividend of $1.50 per share was paid with a record date of July 24, 2024, and an ex-dividend date of July 19, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Walgreens Boots Alliance (NASDAQ:WBA).

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 4.21B. The market cap for tickers in the group ranges from 3.29K to 18.71B. WBA holds the highest valuation in this group at 18.71B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was 7%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 3%. ALBBY experienced the highest price growth at 36%, while RADLY experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -73%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 100
Price Growth Rating: 59
SMR Rating: 100
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
SCNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of an online platform for pharmaceutical purchasers

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
N/A
Address
2420 Brunello Trace.
Phone
+1 800 261-0281
Employees
34
Web
https://www.rx.trxade.com